Pinnacle Wealth Management Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,600
Closed -$242K 111
2022
Q3
$242K Hold
1,600
0.21% 92
2022
Q2
$233K Buy
+1,600
New +$233K 0.2% 103
2022
Q1
Sell
-1,600
Closed -$220K 136
2021
Q4
$220K Buy
+1,600
New +$220K 0.16% 114